+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Workflow (Discovery Informatics, Biocontent Management), Services (Sequence Analysis Platform), Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 120 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 4582042
Description Jump to:
The global drug discovery informatics market size is expected to reach USD 6.86 billion by 2030, registering a CAGR of 11.2% from 2023 to 2030. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use Artificial Intelligence (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent Covid-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid Covid-19 drug discovery. Hence, the need to facilitate drug development for Covid-19 is expected to propel the industry expansion over the coming years.

Drug Discovery Informatics Market Report Highlights

  • The drug development workflow segment is projected to exhibit the highest compound annual growth rate (CAGR) of 10.9% from 2022 to 2030 owing to a rise in the number of drug candidates in the clinical development phase
  • The discovery informatics segment accounted for the largest revenue share of around 60% in 2022, with a major focus on developing precision medicines. Precision medicine revolves around providing personalized medical care tailored to an individual's genetic and molecular profile.
  • Led by the U.S., North America led the global market in 2022 due to the presence of key market players and established R&D infrastructure in the country
  • Key industry participants focus on strategic acquisitions to sustain the market competition


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Workflow
1.1.2. Services
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Workflow outlook
2.2.2. Services outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Drug Discovery Informatics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Drug Discovery Informatics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Drug Discovery Informatics: Workflow Estimates & Trend Analysis
4.1. Drug Discovery Informatics Market: Key Takeaways
4.2. Drug Discovery Informatics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Discovery Informatics
4.3.1. Discovery Informatics market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Biocontent Management
4.4.1. Biocontent Management market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Drug Discovery Informatics: Services Estimates & Trend Analysis
5.1. Drug Discovery Informatics Market: Key Takeaways
5.2. Drug Discovery Informatics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Sequence Analysis Platform
5.3.1. Sequence analysis platform market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Molecular Modelling
5.4.1. Molecular Modelling market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Docking
5.5.1. Docking market estimates and forecasts, 2018 to 2030 (USD Billion)
5.6. Clinical Trial Data Management
5.6.1. Clinical Trial Data Management market estimates and forecasts, 2018 to 2030 (USD Billion)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Drug Discovery Informatics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Drug Discovery Informatics Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.5. Asia-Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Certara
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Boehringer Ingelheim International GmbH
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Infosys Ltd.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Charles River Laboratories
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Collaborative Drug Discovery, Inc.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Eurofins DiscoverX Products
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Jubilant Biosys
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Selvita
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Novo Informatics Pvt. Ltd.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. ChemAxon Ltd.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Albany Molecular Research Inc.
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Oracle
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Accenture
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. Agilent Technologies, Inc.
7.2.14.1. Company overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives
7.2.15. Illumina, Inc.
7.2.15.1. Company overview
7.2.15.2. Financial performance
7.2.15.3. Product benchmarking
7.2.15.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 3 North America drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 4 North America drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 5 U.S. drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 6 U.S. drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 7 U.S. drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 8 Canada drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 9 Canada drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 10 Canada drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 11 Europe drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 12 Europe drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 13 Europe drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 14 Germany drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 15 Germany drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 16 Germany drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 17 UK drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 18 UK drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 19 UK drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 20 France drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 21 France drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 22 France drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 23 Italy drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 24 Italy drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 25 Italy drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 26 Spain drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 27 Spain drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 28 Spain drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 29 Sweden drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 30 Sweden drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 31 Sweden drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 32 Norway drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 33 Norway drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 34 Norway drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 35 Denmark drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 36 Denmark drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 37 Denmark drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 38 Asia-Pacific drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 39 Asia-Pacific drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 40 Asia-Pacific drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 41 China drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 42 China drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 43 China drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 44 Japan drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 45 Japan drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 46 Japan drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 47 India drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 48 India drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 49 India drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 50 Thailand drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 51 Thailand drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 52 Thailand drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 53 South Korea drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 54 South Korea drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 55 South Korea drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 56 Latin America drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 57 Latin America drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 58 Latin America drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 59 Brazil drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 60 Brazil drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 61 Brazil drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 62 Mexico drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 63 Mexico drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 64 Mexico drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 65 Argentina drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 66 Argentina drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 67 Argentina drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 68 Middle East and Africa drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 69 Middle East and Africa drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 70 Middle East and Africa drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 71 South Africa drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 72 South Africa drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 73 South Africa drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 74 Saudi Arabia drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 75 Saudi Arabia drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 76 Saudi Arabia drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 77 UAE drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 78 UAE drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 79 UAE drug discovery informatics market, by region, 2018-2030 (USD Million)
Table 80 Kuwait drug discovery informatics market, by workflow, 2018-2030 (USD Million)
Table 81 Kuwait drug discovery informatics market, by services, 2018-2030 (USD Million)
Table 82 Kuwait drug discovery informatics market, by region, 2018-2030 (USD Million)
List of Figures
Fig.1 Market research process
Fig.2 Data triangulation techniques
Fig.3 Primary research pattern
Fig.4 Market research approaches
Fig.5 Value-chain-based sizing & forecasting
Fig.6 QFD modeling for market share assessment
Fig.7 Market formulation & validation
Fig.8 Drug Discovery Informatics s: market outlook
Fig.9 Drug Discovery Informatics s competitive insights
Fig.10 Parent market outlook
Fig.11 Related/ancillary market outlook
Fig.12 Penetration and growth prospect mapping
Fig.13 Industry value chain analysis
Fig.14 Drug Discovery Informatics market driver impact
Fig.15 Drug Discovery Informatics market restraint impact
Fig.16 Drug Discovery Informatics market strategic initiatives analysis
Fig.17 Drug Discovery Informatics market: Workflow movement analysis
Fig.18 Drug Discovery Informatics market: Workflow outlook and key takeaways
Fig.19 Discovery informatics market estimates and forecasts, 2018-2030 (USD Million)
Fig.20 Biocontent management market estimates and forecasts, 2018-2030 (USD Million)
Fig.21 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig.22 Drug Discovery Informatics market: Services movement analysis
Fig.23 Drug Discovery Informatics market: Services outlook and key takeaways
Fig.24 Sequence analysis platforms market estimates and forecasts, 2018-2030 (USD Million)
Fig.25 Molecular modelling market estimates and forecasts, 2018-2030 (USD Million)
Fig.26 Docking market estimates and forecasts, 2018-2030 (USD Million)
Fig.27 Clinical trial data management market estimates and forecasts, 2018-2030 (USD Million)
Fig.28 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig.29 Global Drug Discovery Informatics market: regional movement analysis
Fig.30 Global Drug Discovery Informatics market: regional outlook and key takeaways
Fig.31 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig.32 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig.33 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig.34 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig.35 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig.36 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig.37 France market estimates and forecasts, 2018-2030 (USD Million)
Fig.38 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig.39 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig.40 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig.41 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig.42 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig.43 Asia-Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig.44 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig.45 China market estimates and forecasts, 2018-2030 (USD Million)
Fig.46 India market estimates and forecasts, 2018-2030 (USD Million)
Fig.47 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig.48 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig.49 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig.50 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig.51 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig.52 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig.53 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig.54 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Million)
Fig.55 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig.56 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig.57 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig.58 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Certara
  • Boehringer Ingelheim International GmbH
  • Infosys Ltd.
  • Charles River Laboratories
  • Collaborative Drug Discovery, Inc.
  • Eurofins DiscoverX Products
  • Jubilant Biosys
  • Selvita
  • Novo Informatics Pvt. Ltd.
  • ChemAxon Ltd.
  • Albany Molecular Research Inc.
  • Oracle
  • Accenture
  • Agilent Technologies, Inc.
  • Illumina, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedDecember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2.96 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.86 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Drug Discovery Informatics Market by Solutions (Services, Software), Functions (Docking, Libraries & Database Preparation, Molecular Modeling), End-User, Application - Forecast 2024-2030 - Product Image

Global Drug Discovery Informatics Market by Solutions (Services, Software), Functions (Docking, Libraries & Database Preparation, Molecular Modeling), End-User, Application - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - Product Image

Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030

  • Report
  • 220 Pages
  • Global
Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 145 Pages
  • Global
From
Drug Discovery Informatics Global Market Report 2024 - Product Image

Drug Discovery Informatics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Drug Discovery Informatics - Global Strategic Business Report - Product Image

Drug Discovery Informatics - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.